Barrick Mining Corporation Common Shares (B)
46.20
-1.44 (-3.02%)
NYSE · Last Trade: Feb 12th, 1:23 PM EST
Detailed Quote
| Previous Close | 47.64 |
|---|---|
| Open | 47.96 |
| Bid | 46.19 |
| Ask | 46.21 |
| Day's Range | 45.54 - 47.96 |
| 52 Week Range | 17.41 - 54.69 |
| Volume | 11,905,987 |
| Market Cap | 2.34B |
| PE Ratio (TTM) | -60.00 |
| EPS (TTM) | -0.8 |
| Dividend & Yield | 0.4000 (0.87%) |
| 1 Month Average Volume | 17,913,450 |
Chart
About Barrick Mining Corporation Common Shares (B)
Barnes Group Inc. is a global provider of highly engineered products, systems, and services for various industries including aerospace, transportation, and industrial manufacturing. The company operates through two primary segments: the Industrial segment, which offers precision components and industrial supplies, and the Aerospace segment, which focuses on manufacturing and supplying critical aircraft components and aftermarket services. Barnes Group is dedicated to innovation and quality, leveraging advanced technologies and materials to meet the evolving needs of its customers while maintaining a strong commitment to sustainability and operational excellence. Read More
News & Press Releases

iShares MSCI Global Gold Miners ETF tracks a global index of gold mining firms, offering targeted exposure to the sector’s performance.
Via The Motley Fool · February 11, 2026
Spot silver prices jumped 6.5% to $86 an ounce while spot gold gained 1.8% to $5,113.6 per ounce at the time of writing.
Via Stocktwits · February 11, 2026
Barrick Mining Corp. (NYSE:B) Emerges as a Strong CAN SLIM Candidatechartmill.com
Via Chartmill · February 11, 2026
Plainsboro, NJ, US and Bagsværd, Denmark, February 9, 2026 – Novo Nordisk announced today that it has filed a lawsuit against telehealth company Hims & Hers (“Hims”), for infringing US Patent 8,129,343 with Hims’ compounded semaglutide products for the US market. Hims has engaged in promotional campaigns that highlight its compounded semaglutide products, duping consumers and healthcare professionals as to the clinical benefits and safety of these unapproved drugs. This includes Hims’ recent launch, and two days later, abrupt discontinuance of its “Compounded GLP-1 Pill,” which came on the heels of Novo Nordisk’s introduction of the Wegovy® pill, the first and only FDA-approved GLP-1 pill for weight loss. Hims continues to unlawfully mass compound injectable versions, made with inauthentic API, and these knock-offs are putting patient health and wellbeing at risk.
By Novo Nordisk A/S · Via GlobeNewswire · February 9, 2026
Barrick Mining Corp (NYSE:B) Shows High Growth Momentum and Technical Breakout Setupchartmill.com
Via Chartmill · January 26, 2026
Barrick Mining Corp (NYSE:B) Emerges as a Top Affordable Growth Stock Pickchartmill.com
Via Chartmill · January 24, 2026
Via MarketBeat · February 7, 2026
Gold is a highly volatile commodity, and a small miner with a big mining project could be a risky way to get involved.
Via The Motley Fool · February 5, 2026
Barrick (B) Q4 2025 Earnings Call Transcript
Via The Motley Fool · February 5, 2026
Bagsværd, Denmark and Plainsboro, NJ, 5 February 2026 – Novo Nordisk today issued the following statement regarding the announcement by Hims & Hers that they will unlawfully mass-market an unapproved, inauthentic, and untested knockoff semaglutide pill.
By Novo Nordisk A/S · Via GlobeNewswire · February 5, 2026
Barrick posted a substantial earnings increase in the fourth quarter but expects gold and copper production for 2026 to be slightly lower than 2025 levels.
Via Stocktwits · February 5, 2026
Record shareholder returns and another record quarterly financial performance mark successful delivery of 2025 operating plan
By Barrick Mining Corporation · Via GlobeNewswire · February 5, 2026
All amounts expressed in U.S. dollars
By Barrick Mining Corporation · Via GlobeNewswire · February 5, 2026
Robert Samek and Mark Hill join Board of Directors
By Barrick Mining Corporation · Via GlobeNewswire · February 5, 2026
Spot silver price was up 1.3% at $86.4 an ounce at the time of writing, after having jumped more than 5% to reclaim $90 earlier in the session.
Via Stocktwits · February 4, 2026
Savvy investors could want to take advantage of the recent sell-off and go for the gold.
Via The Motley Fool · February 4, 2026
Spot gold climbed 5.8% higher to $4,931.6 an ounce, while spot silver shot up nearly 12% to $88.8 an ounce.
Via Stocktwits · February 3, 2026
Small-cap stocks can be incredibly lucrative investments because their lack of analyst coverage leads to frequent mispricings.
However, these businesses (and their stock prices) often stay small because their subscale operations make it harder to expand their competitive moats.
Via StockStory · February 2, 2026
Gold, Silver Continue To Decline – Analysts Warn Of Crowded Trades As Precious Metals Extend ‘Historic Rout’stocktwits.com
Via Stocktwits · February 2, 2026
President Trump's nominee let Wall Street breathe a sigh of relief, but that's not great for gold prices.
Via The Motley Fool · January 30, 2026
Spot gold prices slumped more than 8% on Friday, falling below the $5,000 an ounce for the first time since January 23, while spot silver plummeted to $91.6 per ounce from $115.6 in the previous session.
Via Stocktwits · January 30, 2026
Newmont's gold-mining stock looks cheap. Scotiabank thinks you should buy it.
Via The Motley Fool · January 26, 2026
Explore how differing exposures to gold and mining stocks shape the risk, cost, and diversification profiles of these two popular ETFs.
Via The Motley Fool · January 25, 2026
Investors often group gold ETFs together, but the VanEck Gold Miners ETF (GDX) and the SPDR Gold MiniShares Trust (GLDM) respond to gold prices in different ways. Here's what sets them apart.
Via The Motley Fool · January 21, 2026
Barrick Mining sits on a treasure trove of gold and copper and some analysts believe the high-flying stock is undervalued.
Via The Motley Fool · January 21, 2026